A detailed history of Fieldpoint Private Securities, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 5 shares of GKOS stock, worth $754. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 19 73.68%
Holding current value
$754
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$34.86 - $63.77 $488 - $892
-14 Reduced 73.68%
5 $0
Q4 2021

Jan 24, 2022

SELL
$40.27 - $56.99 $604 - $854
-15 Reduced 44.12%
19 $1,000
Q3 2021

Nov 12, 2021

BUY
$47.43 - $84.23 $901 - $1,600
19 Added 126.67%
34 $2,000
Q2 2021

Aug 12, 2021

SELL
$73.06 - $97.7 $2,557 - $3,419
-35 Reduced 70.0%
15 $1,000
Q1 2021

Apr 23, 2021

BUY
$70.43 - $97.42 $1,056 - $1,461
15 Added 42.86%
50 $4,000
Q4 2020

Jan 28, 2021

BUY
$48.9 - $75.26 $1,711 - $2,634
35 New
35 $3,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.